TLYB Stock Chart & Stats
€6.55
€0.00(0.00%)
At close: 4:00 PM EDT
€6.55
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€3.79 - €6.70
Previous CloseN/A
Volume0.00
Average Volume (3M)813.00
Market Cap
€2.87B
Enterprise Value€3.47B
Total Cash (Recent Filing)€344.00M
Total Debt (Recent Filing)€1.29B
Price to Earnings (P/E)25.0
Beta0.04
Next Earnings
Nov 05, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding445,450,000
10 Day Avg. Volume1,433
30 Day Avg. Volume813
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.00
Price to Sales (P/S)0.80
P/FCF Ratio13.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.20Price Target Upside-5.28% Downside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€23.71M
Bulls Say, Bears Say
Bulls Say
Cross Selling SuccessTate & Lyle states that it is seeing initial cross selling success with the pipeline having more than doubled over the last 2 months.
Future EBITDA RecoveryThe expected recovery of adjusted EBITDA back to pro forma FY25 levels is anticipated after a decline.
Revenue SynergiesThe CP Kelco acquisition should provide future revenue synergies, enhancing the company's financial performance.
Bears Say
Guidance DowngradeThe delta of the downgrade to the guidance is more significant than peers, and hence the shares are expected to underperform the sector and overall track lower.
Market Demand ChallengesTate & Lyle is navigating a challenging period driven by weak demand, marked by cumulative organic volume declines since FY23.
Market Demand SlowdownTate & Lyle states that it has observed a slowdown in market demand which has affected recent performance and hence is reducing the 1H25/26 outlook and FY25/26 guidance.
Tate & Lyle News
TLYB FAQ
What was Tate & Lyle’s price range in the past 12 months?
Tate & Lyle lowest stock price was €3.79 and its highest was €6.70 in the past 12 months.
What is Tate & Lyle’s market cap?
Tate & Lyle’s market cap is €2.87B.
When is Tate & Lyle’s upcoming earnings report date?
Tate & Lyle’s upcoming earnings report date is Nov 05, 2026 which is in 98 days.
How were Tate & Lyle’s earnings last quarter?
Tate & Lyle released its earnings results on May 21, 2026. The company reported €0.224 earnings per share for the quarter, beating the consensus estimate of €0.181 by €0.043.
Is Tate & Lyle overvalued?
According to Wall Street analysts Tate & Lyle’s price is currently Overvalued.
Does Tate & Lyle pay dividends?
Tate & Lyle does not currently pay dividends.
What is Tate & Lyle’s EPS estimate?
Tate & Lyle’s EPS estimate is 0.24.
How many shares outstanding does Tate & Lyle have?
Tate & Lyle has 445,450,000 shares outstanding.
What happened to Tate & Lyle’s price movement after its last earnings report?
Tate & Lyle reported an EPS of €0.224 in its last earnings report, beating expectations of €0.181. Following the earnings report the stock price went up 2.573%.
Which hedge fund is a major shareholder of Tate & Lyle?
Currently, no hedge funds are holding shares in DE:TLYB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tate & Lyle Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€6.20 (-5.28% Downside)
€6.20 (-5.28% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.13%
12-Months-Change
Fundamentals
Return on Equity
3.56%
Trailing 12-Months
Asset Growth
-1.74%
Trailing 12-Months
Company Description
Tate & Lyle
Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.
TLYB Stock 12 Month Forecast
Average Price Target
€6.20
▼(-5.28% Downside)